Tauro-α-muricholic acid sodium

Overview

Tauro-α-muricholic acid sodium (T-α-MCA sodium) is a Taurine ( HY-B0351 )-conjugated primary Bile acid. Tauro-α-muricholic acid sodium is a FXR antagonist with an IC 50 of 28 µM. Tauro-α-muricholic acid sodium attenuates other bile acid-activated FXR signaling. Tauro-α-muricholic acid sodium can be used in the research of Alzheimer's disease, glucose metabolism, and lipid metabolism.

Application

Products | Products > Disease Areas > Alzheimer's Disease | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Glucose Metabolism | Products > Disease Areas > Lipid Metabolism | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Endogenous Metabolite | Products > Signaling Pathways > FXR

Product Information

• Catalog No.: HY-133890A
• CAS No.: 2260905-08-4
• Molecular Formula: C26H44NNaO7S
• Molecular Weight: 537.68
• Purity: 99.9%
• Storage: -20°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Availability: In-stock

Source

Original product source